Navigation Links
Proximal in Biological Technology

Cardica Announces Fiscal 2009 Second Quarter Financial Results

... "Clinical adoption of our PAS-Port(R) proximal Anastomosis System by cardiothoracic surgeons for ... United States and Europe and its PAS-Port(R) proximal Anastomosis System is marketed in the United ... C-Port Distal Anastomosis Systems and PAS-Port proximal Anastomosis System, manufacturing of the C-Port ...

Cardica Announces Fiscal 2009 First Quarter Financial Results

... - PAS-Port(R) proximal Anastomosis System Received 510(k) Clearance from ... in the United States and Europe. The PAS-Port(R) proximal Anastomosis System is marketed in the United ... C-Port Distal Anastomosis Systems and PAS-Port proximal Anastomosis System, manufacturing of the C-Port ...

FDA Approves Boston Scientific's Express(R) SD Renal Stent System

... It is the only FDA-approved renal stent designed to provide additional proximal end support. "The approval of the Express SD Stent for renal ... of the renal arteries by incorporating additional connections in the proximal end of the stent, which are intended to provide excellent support, ...

RADI Medical Systems Launches Next Generation PressureWire(R) Certus

... of the PressureWire(R) Certus features a new ergonomically designed proximal connector which provides three key advantages for physicians. The new large entry funnel allows for fast and easy wire reconnection into the proximal connector, while also exhibiting less insertion friction. In addition, the ...

Cardica Announces Fiscal 2008 Second Quarter Financial Results and Business Progress

... quarter; -- Increased cumulative worldwide shipments of PAS-Port(R) proximal Anastomosis Systems to over 7,300 units, with more than 560 units sold ... Systems are marketed in Europe and the United States. The PAS-Port(R) proximal Anastomosis System is marketed in Europe and Japan and is being evaluated ...

DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation

... is formulated for oral administration in GI GVHD patients as a single product consisting of two tablets; one tablet is intended to release BDP in the proximal portions of the GI tract, and the other tablet is intended to release BDP in the distal portions of the GI tract. In addition to issued patents ...

Successful Field-Trial Remediation of 1,2-DCA and VC Contaminated Groundwater in Northern Italy

... m3. A total of 6,300 kg of EHC amendment was injected through nine injection points using direct-push technology. Groundwater monitoring from four proximal observation wells showed a widespread and sustained reduction in redox (Eh -150 mV to -450 mV) and, most significantly, within ca. 9 months the ...

Arizona Heart Institute First to Implant Powerlink XL in Phoenix, Arizona Since FDA Approval

... profile device on the market to treat aortic necks in excess of 26 millimeters and is the only available device with both infrarenal and suprarenal proximal extensions, allowing physicians to choose the best device for each patient's anatomy. Arizona Heart Institute is a cardiovascular specialty ...

Prominent Urologist Dr. David B. Samadi Presents Breakthrough Robotic Surgery Techniques on OR Live Webcast

... the cavernous nerves causes erectile dysfunction. These nerves course laterally along the prostate and rectum and provide nerve connections to the proximal penis deep in the pelvis. If they are damaged, erectile function is, too. Put simply, preserving the cavernous nerves preserves sexual potency. There ...

Northern Antibiotics Presents New Data on Novel Polymyxin Compounds at the Joint ICAAC/IDSA 2008

... and polymyxin B, the NAB compounds are excreted into urine to a significant extent. This indicates that the reuptake of the NAB compounds in the proximal tubuli of the kidneys is less intense than that of colistin and polymyxin B. The extensive reuptake is regarded to be the mechanism of ...

Cardica Receives $1 Million Milestone Payment From Cook Medical for Development of Heart Defect Closure Device

... aspect of the CABG procedure. Cardica's C-Port(R) Distal Anastomosis Systems are marketed in Europe and the United States. The PAS-Port(R) proximal Anastomosis System is marketed in Europe and Japan, and Cardica has received 510(k) clearance to market the PAS-Port system in the United States. ...

Cardica to Present at Jefferies 2nd Annual Healthcare Conference

... aspect of the CABG procedure. Cardica's C-Port(R) Distal Anastomosis Systems are marketed in Europe and the United States. The PAS-Port(R) proximal Anastomosis System is marketed in Europe and Japan, and Cardica has submitted a 510(k) premarket notification for clearance to market the PAS-Port ...

Cardica and Intuitive Surgical to Host Educational Symposium on 'Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair'

... aspect of the CABG procedure. Cardica's C-Port(R) Distal Anastomosis Systems are marketed in Europe and the United States. The PAS-Port(R) proximal Anastomosis System is marketed in Europe and Japan and is being evaluated in a pivotal trial in the United States and Europe. Cardica also is ...

Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons

... aspect of the CABG procedure. Cardica's C-Port(R) Distal Anastomosis Systems are marketed in Europe and the United States. The PAS-Port(R) proximal Anastomosis System is marketed in Europe and Japan and is being evaluated in a pivotal trial in the United States and Europe. Cardica also is ...

Cardica and Cook Sign Agreement to Expand Cook Vascular Closure Device Product Family

... critical aspect of the CABG procedure. Cardica's C-Port(R) Distal Anastomosis Systems are marketed in Europe and the United States. The PAS-Port(R) proximal Anastomosis System is marketed in Europe and Japan and is being evaluated in a pivotal trial in the United States and Europe. Cardica also is ...

Cardica Receives European CE Mark for C-Port Flex A System for Use in Coronary Artery Bypass Surgery

... critical aspect of the CABG procedure. Cardica's C-Port(R) Distal Anastomosis Systems are marketed in Europe and the United States. The PAS-Port(R) proximal Anastomosis System is marketed in Europe and Japan and is being evaluated in a pivotal trial in the United States and Europe. Cardica also is ...

Cardica's C-Port(R) Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed-Chest Heart Bypass Surgeries

... critical aspect of the CABG procedure. Cardica's C-Port(R) Distal Anastomosis Systems are marketed in Europe and the United States. The PAS-Port(R) proximal Anastomosis System is marketed in Europe and Japan and is being evaluated in a pivotal trial in the United States and Europe. Cardica also is ...

Laser Capture Microdissection (LCM) for the Analysis of Macrophage Gene Expression from Atherosclerotic Lesions

... transparent LCM caps over selected regions. 30 proximal aortic sections from each apolipoprotein ... laser captured lesional macrophage RNA from proximal aortas of LPS and control stimulated ... vehicle only and, ~4 hours after treatment, the proximal aortas were processed for each mouse as described ...

Quantitative Analysis of Protein-DNA Associations in Vivo Using Real-Time PCR, Rev A

... of the glucagon promoter, designated as Gluc(1) and Gluc(2). These two regions are located approximately 300 bp apart in the proximal glucagon promoter. For real-time PCR reactions, 3 l of each immunoprecipitated sample was used as template in 25 l reactions ...

A Multiple Mutation Model System as a Test Development and Training Tool for Denaturing Gradient Gel Electrophoresis

... the 5' HinFI amplicon) (Figure 3a). The second re-design used a non-clamped version of the 5' primer and a 3' GC-clamped primer proximal to the HinFI site (termed the 3' HinFI amplicon) (Figure 3b). A third primer pair was synthesized to include the region of exon ...

YOUR DATA: Direct Real-time RT-PCR on Sympathetic Neuron Lysates Silencing of Focal Adhesion Kinases with Silencer Validated siRNAs

... signaling. Dr. Joseph Loftus of the Mayo Clinic, Scottsdale has been examining the role of two potential proximal integrin effectors--the closely related focal adhesion kinases FAK (PTK2) and Pyk2 (PTK2B) -- in the ...

YOUR DATA: Direct Real-time RT-PCR on Sympathetic Neuron Lysates Silencing of Focal Adhesion Kinases with Silencer Validated siRNAs

... signaling. Dr. Joseph Loftus of the Mayo Clinic, Scottsdale has been examining the role of two potential proximal integrin effectors--the closely related focal adhesion kinases FAK (PTK2) and Pyk2 (PTK2B) -- in the ...

TKB1 Cells Identify Receptor Tyrosine Kinase Interacting Proteins

... phosphorylation (Y1028, Y1144, Y1201, Y1226/7, and Y1253), which we renamed (to simplify) sites A through E in a membrane proximal to distal fashion. Three GST fusion proteins were constructed to individually contain phosphorylation sites Y1201, Y1226/7, and ...
Other Contents
(Date:11/12/2014)... 2014 Crossmatch™, a leading provider of biometric ... fingerprint readers have been deployed throughout Montparnasse Pasteleria, ... Mexico . The bakery chain implemented the Crossmatch ... caused by employees clocking in for each other. ... Montparnasse relied on paper timecards and a mechanical time ...
(Date:11/7/2014)... 7, 2014  In conjunction with the Glendale ... The Community Foundation of the Verdugos has announced the " ... PROJECT," a $250,000 initiative to keep the Verdugo Regional Crime ... first six months of existence, the Lab has processed more ... local law enforcement. "Because our number one priority ...
(Date:11/6/2014)... that predator runs so fast that it essentially blinds itself. ... fastest creature on Earth. Some of these half-inch-long beetles cover ... per hour). The fastest human can do about five body ... a person would have to hit 480 miles per hour. ... speeds, everything becomes a blur. They can,t gather enough light ...
Breaking Biology News(10 mins):Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2The tiger beetle: Too fast to see 2
(Date:11/27/2014)... (PRWEB) November 27, 2014 Blood-borne pathogens ... many medical precautions and procedures in place to counter ... and disposal of things tainted with menstrual blood are ... design a simpler, more sanitary way to handle tampons ... an inventor from Sonora, Calif. , He then created ...
(Date:11/27/2014)... 27, 2014 Nearly 1,100 Risperdal ... in a consolidated litigation now underway in Pennsylvania ... Documents recently updated in the Philadelphia Court of ... state proceeding, all of which involve a drug ... psychiatric conditions. Many of the cases in this ...
(Date:11/27/2014)... HealthDay Reporter WEDNESDAY, Nov. 26, 2014 ... safe and produces an immune system response that could protect ... results reported by the U.S. National Institutes of Health. ... vaccine paves the way for field-testing it in the Ebola-stricken ... as January, said Dr. Anthony Fauci, director of the NIH,s ...
(Date:11/27/2014)... NY (PRWEB) November 27, 2014 The founders ... offering stylish, comfortable and high functioning compression socks, are proud ... newly-released socks use an innovative Gradient Pressure (TM) knitting technology ... blood. , VIM & VIGR’s commitment to adding flair and ... as just functional recently caught the eye of a writer ...
(Date:11/27/2014)... 27, 2014 Tylenol lawsuits ( http://www.tylenollawsuitcenter.com/ ... injured by the medication are continuing to move forward ... looking ahead to a status conference in December, Bernstein ... Order issued earlier this year, a conference in the ... 10:00 a.m. Items likely to be discussed at the ...
Breaking Medicine News(10 mins):Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 2Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 3Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 4Health News:Early Trial Promising for Ebola Vaccine 2Health News:Early Trial Promising for Ebola Vaccine 3Health News:VIM & VIGR Announces Launch of Men’s Line of Compression Socks 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 3
Other TagsOther Tags